Skip to content
zameds

Acetylcysteine (Acc, Acc On The Go, Acetylcysteine Clicks, Acetylcysteine Sandoz, Acetylcysteine Hexal, Acc Hot)

Acetylcysteine

Sandoz South Africa (Pty) Ltd

Registration

Applicant
Sandoz South Africa (Pty) Ltd
Certificate holder
Sandoz SA (Pty) Ltd
Registrations
7

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Acc 200

EACH TABLET CONTAINS ACETYLCYSTEINE 200 mg

200 mgEffervescent tablets29075329/10.2.2/0753Approved 19 April 2013RegisteredNot determinedPIL
Acc 600600 mgEffervescent tablets45022945/10.3/0229Approved 28 March 2025RegisteredNot determinedPIPIL
Acc on the go

Each Sachet contains: Acetylcystene 600,0 mg

Not listed51081651/10.3/0816RegisteredNot determinedNone
Acetylcysteine 200 clicks

EACH TABLET CONTAINS ACETYLCYSTEINE 200,0 mg

20058022258/10.3/0222RegisteredNot determinedNone
Acetylcysteine 600 sandoz

EACH TABLET CONTAINS ACETYLCYSTEINE 600,0 mg

60059006059/10.3/0060RegisteredNot determinedNone
Acetylcysteine 600 hexal

EACH TABLET CONTAINS ACETYLCYSTEINE 600,0 mg

600590061.06059/10.3/0061.060RegisteredNot determinedNone
Acc 600 hot

EACH SACHET CONTAINS: ACETYLCYSTEINE 600,0 mg

60059040659/10.3/0406RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S3: Acetylcysteine

    • when intended for injection or for the management of paracetamol overdosage;
    • except when used as a mucolytic in acute respiratory conditions for a maximum treatment period of 14 days. (S1)

    Consolidated Schedules 06 July 2026, lines 3109 to 3114

  • S1: Acetylcysteine

    • when used as a mucolytic in acute respiratory conditions for a maximum treatment period of 14 days;
    • except when intended for injection or for the management of paracetamol overdosage. (S3)

    Consolidated Schedules 06 July 2026, lines 102 to 106

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C5H9NO3S163.20 g/mol

(2R)-2-Acetamido-3-sulfanylpropanoic acid

Drag to rotate. Structure from PubChem CID 12035.

SAHPRA documents

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles